
Urenus Pharmaceutical Private Limited
About Urenus Pharmaceutical Private Limited
Data last updated:
Urenus Pharmaceutical Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2021PTC148895.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Devikiran Kumar Viswanath Nistala and Ramaraju Didyala.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S No 14 20 21 22 23 101 A Block Western Plaza Dargah Hussain Shahwali, Hyderabad, Telangana, India – 500008.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.88 Lakh, a growth of 53% compared to the previous year. For the same year it recorded a net profit of ₹2.88 Lakh (net margin 9.3%) and EBITDA of ₹2.88 Lakh (EBITDA margin 9.3%).
Company details
Contact details
Urenus Pharmaceutical Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressS No 14 20 21 22 23 101 A Block Western Plaza Dargah Hussain Shahwali, Hyderabad, Telangana, India – 500008
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Urenus Pharmaceutical is hospital and medical care. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Urenus Pharmaceutical Private Limited, buy the company report.
Financials of Urenus Pharmaceutical Private Limited
FY 2025 filings availableUrenus Pharmaceutical Private Limited reported revenue of ₹30.88 Lakh (up 53% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 53% in the latest year. EBITDA rose 59% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2.88 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.88 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 9.3% | |||
| Net Profit Margin | 9.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Urenus Pharmaceutical Private Limited, buy the company report.
Board of directors of Urenus Pharmaceutical Private Limited
Urenus Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devikiran Kumar Viswanath Nistala Also directs: Vishwa Shiva Ram Pharma Private Limited, Sri RK Pro Medical Services LLP, Medjacket India Private Limited and 1 more | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
| Ramaraju Didyala Also directs: Samiksha Infra Developers LLP, Glims Broadcasting Private Limited, Vishwa Shiva Ram Pharma Private Limited and 3 more | Director | 22 Feb 2021 | 5 Years 8 Months | Current |
Peer comparison
Urenus Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pikale Healthcare Private Limited | ₹31.33 Lakh (FY 2025) | 85.0% | Mumbai, Maharashtra, India | |||
| Prakash Maternity Centre Private Limited | ₹31.14 Lakh (FY 2025) | 20.0% | Patna, Bihar, India | |||
| Cassiopeia Pharmaceuticals Private Limited | ₹31.08 Lakh (FY 2024) | 21.0% | Lucknow, Uttar Pradesh, India | |||
| Malwa Diagnostics Private Limited | ₹30.98 Lakh (FY 2024) | 6.0% | Indore, Madhya Pradesh, India | |||
| Moctiva Pharma Private Limited | ₹30.98 Lakh (FY 2025) | 117.0% | Noida, Uttar Pradesh, India | |||
| Urenus Pharmaceutical Private Limitedthis company | ₹30.88 Lakh (FY 2024) | ₹2.88 Lakh | 9.3% | 53.0% | Hyderabad, Telangana, India | |
| Lavanya Ayurvedic Private Limited | ₹30.62 Lakh (FY 2024) | 21.0% | Lucknow, Uttar Pradesh, India | |||
| Riprasu Services Private Limited | ₹30.56 Lakh (FY 2024) | Khagaria, Bihar, India | ||||
| Pmsrc Diagnostics Private Limited | ₹30.55 Lakh (FY 2025) | -23.0% | Palakkad, Kerala, India | |||
| Urban Pathlabs Private Limited | ₹30.4 Lakh (FY 2025) | -29.0% | Patna, Bihar, India | |||
| Patel Medical Centre Private Limited | ₹30.36 Lakh (FY 2025) | 5.0% | Barabanki, Uttar Pradesh, India |
To see the full peer comparison of Urenus Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Urenus Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Urenus Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Urenus Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Urenus Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Devikiran Kumar Viswanath Nistala was appointed as Director on 22 Feb 2021.
Frequently asked questions
Urenus Pharmaceutical is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 2021 (5+ years old) and is registered under CIN U24110TG2021PTC148895.
Urenus Pharmaceutical has 2 current directors:
- Devikiran Kumar Viswanath Nistala - Director
- Ramaraju Didyala - Director
The latest financial statements of Urenus Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Urenus Pharmaceutical is U24110TG2021PTC148895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Urenus Pharmaceutical was incorporated on 22 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Urenus Pharmaceutical by revenue are Pikale Healthcare Private Limited, Prakash Maternity Centre Private Limited, Cassiopeia Pharmaceuticals Private Limited, Malwa Diagnostics Private Limited, Moctiva Pharma Private Limited and 5 more, all in the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).
Devikiran Kumar Viswanath Nistala was appointed as Director on 22 Feb 2021. Ramaraju Didyala was appointed as Director on 22 Feb 2021.
The registered office of Urenus Pharmaceutical is at S No 14 20 21 22 23 101 A Block Western Plaza Dargah Hussain Shahwali, Hyderabad, Telangana, India – 500008.
Urenus Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Urenus Pharmaceutical can be reached at its registered office: S No 14 20 21 22 23 101 A Block Western Plaza Dargah Hussain Shahwali, Hyderabad, Telangana, India – 500008.
Urenus Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.

